Annexon Inc — Quarterly Financial Statistics (NASDAQ:ANNX) | MetaTrader

Open full chart

Financials

Overview Relevé Statistics

Quarterly Annual

Cash from operating activities -36.02 M-50.05 M-38.07 M-52.3 M-45.93 M -186.36 M Cash from investing activities 1.01 M97.62 M73.08 M45.87 M-26.52 M 190.05 M Cash from financing activities 4.97 M59 K153 K13.56 M95.08 M 108.86 M Free cash flow -36.02 M-50.13 M-38.09 M-52.35 M-45.93 M -186.49 M

Nouvelles

Jefferies réitère sa recommandation sur Annexon Biosciences suite à l’activité de fusions-acquisitions

Are Medical Stocks Lagging American Well (AMWL) This Year?

Annexon, Inc. (ANNX) Discusses Vision Preservation in Geographic Atrophy With C1q Inhibition and Key Insights From ARCHER Trials - Slideshow (NASDAQ:ANNX) 2026-03-20

H.C. Wainwright réitère sa recommandation d’achat sur Annexon, objectif de 14$

Annexon Has High-Risk, High-Reward Play On A New Approach To Complement-Mediated Diseases

L’action d’Annexon atteint un sommet de 52 semaines à 7,1 USD

Annexon stock hits 52-week high at 7.1 USD

Annexon, Inc. (ANNX) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow (NASDAQ:ANNX) 2026-01-16

Cantor Fitzgerald réitère sa note sur l’action Annexon Biosciences

Annexon Biosciences stock rating reiterated by Cantor Fitzgerald

Chardan Capital Markets initie la couverture d’Annexon Biosciences avec une recommandation d’achat

Chardan Capital Markets initiates Annexon Biosciences stock with Buy rating